Showing results (291-300 of 349) with videos related to
Sort By:
Pageof 35
Breast Cancer Research : BCR|January 23, 2024
A genome-wide association study of contralateral breast cancer in the Women's Environmental Cancer and Radiation Epidemiology StudyXiaohui Sun, Anne S Reiner, Anh Phong Tran, et al.Journal of the National Cancer Institute|March 29, 2021
Smoking, Radiation Therapy, and Contralateral Breast Cancer Risk in Young WomenAnne S Reiner, Gordon P Watt, Esther M John, et al.Radiology|September 26, 2023
Association of Breast Cancer Odds with Background Parenchymal Enhancement Quantified Using a Fully Automated Method at MRI: The IMAGINE StudyGordon P Watt, Snekha Thakran, Janice S Sung, et al.Journal of Medicinal Chemistry|December 24, 1997
Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonistsM Rowley, J J Kulagowski, A P Watt, et al.The Lancet. Infectious Diseases|April 4, 2015
A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort studyAlexander L Greninger, Samia N Naccache, Kevin Messacar, et al.Journal of the American Chemical Society|January 29, 2025
Electrochemically Driven Selective Olefin Epoxidation by Cobalt-TAML CatalystSuyeon S Kim, Sugyeong Hong, Adarsh Koovakattil Surendran, et al.Bioorganic & Medicinal Chemistry Letters|September 21, 2020
Discovery of a series of ester-substituted NLRP3 inflammasome inhibitorsDavid Harrison, Nicolas Boutard, Krzysztof Brzozka, et al.Journal of Medicinal Chemistry|July 19, 1996
N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonistsT Ladduwahetty, R Baker, M A Cascieri, et al.JAMA Internal Medicine|February 19, 2019
Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016Louise K Francois Watkins, Lesley McGee, Stephanie J Schrag, et al.Journal of the American College of Cardiology|May 26, 2026
Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular riskKausik K Ray, Nicholas Clarke, Peter Thornton, et al.Pageof 35